To amend the Public Health Service Act to nullify certain contractual provisions prohibiting or penalizing a pharmacist's disclosure of the availability of therapeutically equivalent alternative drugs, or alternative methods of purchasing the prescription drug, that are less expensive, and for other purposes.
Prescription Transparency Act of 2018
This bill prohibits contract provisions between a health insurer and a pharmacy that prohibit or penalize a pharmacist's disclosure to an individual purchasing a prescription drug of information regarding (1) the cost of the drug, (2) the availability of any therapeutically equivalent alternative drug, or (3) less expensive methods of purchasing the drug.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line